Skip to main content
Skip to main content

WKU News

Better flu vaccine on the horizon

During the heat of summer, people tend to forget about the flu. Yet as high temperatures begin to decline, we're reminded that influenza, a serious disease that can lead to hospitalization and even death, will soon return.

For the past several months, pharmaceutical companies and U.S. public health officials have been busy making and planning for the distribution of millions of doses of the flu vaccine to protect Americans in the upcoming season. The American Academy of Pediatrics released a new recommendation this week that all children ages 6 months or older be immunized against influenza as soon as the vaccine is available.

Getting vaccinated each year remains the best way to protect yourself against the seasonal flu and lessen the chance you will spread the infection to others.

Despite these efforts, each year between 3,000 and 49,000 people in the United States and approximately 500,000 worldwide die from the flu and its complications. Seasonal flu vaccines reduce the risk of illness in those vaccinated by about 60%, according to the Centers for Disease Control and Prevention. Clearly, we need new improved influenza vaccines to provide an even a better level of protection.

The problem is that for decades the technologies used to make flu vaccines have remained static. This fact, coupled with the intrinsic nature of these viruses to change, has created an untenable situation.

Year-round, scientists, vaccine manufacturers, and public health officials scramble to protect the public against both seasonal and potential pandemic influenza threats, the latter illustrated most recently by the H7N9 bird flu infections in humans occurring in China.

Flu viruses are monitored continually to identify those most likely to cause human illness. But it takes at least six months to produce an influenza vaccine once the targets have been identified; by late February public health officials must choose three or four virus strains expected to be circulating widely the following season.

It's a time-consuming and cumbersome process. These strains usually are grown in eggs (or more recently, in cells), inactivated and then incorporated into next season's flu vaccines.

A major drawback of this strategy is that the circulating flu viruses can evolve significantly while the vaccine is being prepared and deployed, leaving us with a less effective vaccine for the threat at hand. And always looming is the specter of a novel flu virus emerging to which humans have little or no immunity, potentially triggering an influenza pandemic -- as happened in 1918, and again in 1957, 1968 and 2009.

Among the two dozen vaccine-preventable diseases, including measles, mumps, polio, smallpox and hepatitis, seasonal influenza is the only one for which a new vaccine is recommended every year. A more efficient approach is long overdue.

The medical research community has set its sights on developing a revolutionary type of flu vaccine, one to protect against a broad spectrum of flu viruses -- a so-called universal influenza vaccine. Experiments in animals and early phase clinical trials in humans indicate that this concept of broad protection is entirely feasible.

Traditional flu vaccines target regions in the head of a protein found on the surface of the virus, regions readily seen by the immune system but prone to mutations as the viruses carelessly reproduce themselves. In contrast, the new vaccine may target more stable regions of the influenza protein found in the stem, somewhat hidden from the immune system by other molecules nearby, that rarely vary from virus to virus.

Optimally, a universal flu vaccine would protect against both seasonal and potential pandemic flu viruses and provide long-lasting protection so it would be given just once or in a series of boosts, like the measles vaccine.

Realistically, however, a universal flu vaccine likely will be developed in incremental steps rather than in one giant leap -- a flu vaccine given once every ten years, like a tetanus shot, for example, or one shot that offers cross-protection against a subgroup of related influenza viruses is more likely in the short term.

A universal flu vaccine would modernize our prevention strategy, lower health care costs, and bring influenza vaccines more in line with other licensed vaccines.

Much work needs to be done before this goal is reached, and in the meantime, getting an annual flu shot in its current form is still the best protection for everyone. But in 2013, 80 years after scientists discovered that influenza is caused by a virus, we all can be encouraged that research on a transformative approach to influenza prevention is moving ahead.

 

Origional Source:http://www.cnn.com/2013/09/03/health/better-flu-vaccine-fauci/index.html?hpt=he_t2

Categories
All News  Now Viewing Category: All
Media Relations
President Caboni News
CEBS
CHHS News
Gordon Ford College of Business
Ogden News
PCAL
Academic Affairs
WKU Regional Campuses
Glasgow News
Etown & Fort Knox
Owensboro News
Transportation
The Gatton Academy of Mathematics and Science in Kentucky
The Center for Gifted Studies
Police
Emergency Preparedness
Facilities
Housing & Residence Life
Student Activities and Organizations
Augenstein Alumni Center
Campus Activities Board
The Confucius Institute
Cultural Enhancement Series
DELO News
Department of Music
Department of Theatre & Dance
Development and Alumni Relations
Downing Museum
Downing Student Union
Employee Wellness
Hardin Planetarium
Health Services
Human Resources News
Instruments of American Excellence
International Student Office
Kinesiology, Recreation & Sport
Library News
Math News
Office of International Programs
Office of Research
Office of Sustainability
Parent's Association
School of Journalism & Broadcasting
Student Financial Assistance
Scholarships Student Financial Assistance
Student Employment
Student Government Association News
Student Research Council
Study Abroad
Van Meter Auditorium
WellU
WKU Educational Leadership Doctoral Program News
WKU Joint Admissions
WKU Parent and Family Weekend
Latest Headlines
WKU President Caboni visits Glasgow, honors area students

Western Kentucky University President Timothy C. Caboni was honored during a welcome reception at WKU-Glasgow Wednesday afternoon.

WKU's student publications finalists in all 4 Pacemaker categories

For the first time, WKU Student Publications has four finalists for national Pacemaker awards -- one in each category in which the Associated Collegiate Press honors the nation's best student-run publications.

Estate gift to support several areas on WKU campus

WKU has received an estate gift of more than $2.5 million from the late Beulah R. Winchel.

Featured Articles
Estate gift to support several areas on WKU campus

WKU has received an estate gift of more than $2.5 million from the late Beulah R. Winchel.

WKU Police Department to debut new uniforms

The WKU Police Department will be sporting a new look on Saturday afternoon (Sept. 23).

Kappa Delta Sorority to formally receive national honor Sept. 23

The WKU chapter of Kappa Delta Sorority will have plenty to celebrate Sept. 23 as it formally receives Kappa Delta’s highest honor for a collegiate chapter. The award presentation will begin at 11 a.m. at the chapter house, 1600 Chestnut St.

Note: documents in Portable Document Format (PDF) require Adobe Acrobat Reader 5.0 or higher to view,
download Adobe Acrobat Reader.

Note: documents in Excel format (XLS) require Microsoft Viewer,
download excel.

Note: documents in Word format (DOC) require Microsoft Viewer,
download word.

Note: documents in Powerpoint format (PPT) require Microsoft Viewer,
download powerpoint.

Note: documents in Quicktime Movie format [MOV] require Apple Quicktime,
download quicktime.

 
 Last Modified 5/2/17